This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Rheumatoid arthritis and response to anti-TNF alpha therapy: blood |
| Accession | GDS3628 |
| Summary | Analysis of whole blood from rheumatoid arthritis patients at baseline of infliximab therapy. Infliximab is an anti-TNF alpha antibody. Clinical response to infliximab determined at week 14 of therapy. Results identify a gene expression signature for predicting the response to infliximab. |
| Organism | Homo sapiens |
| Platform | GPL2507 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | foo |
| Correction method | BH |
| Cell | TESTOKAY_TO_DELETE |
| Perturbation | TESTOKAY_TO_DELETE |
| Disease | TEST_OKAY_TO_DELETE |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | |
| Up |
|
|
| Down |
|
|
| Combined |
|
